Literature DB >> 18228478

Assays for regulated exocytosis of mast cell granules.

Ulrich Blank1, Juan Rivera.   

Abstract

Mast cells are important effectors in innate and adaptive immune responses. They contain numerous secretory granules filled with inflammatory mediators in their cytoplasm. Exocytosis of granular content does not take place until the cell receives an appropriate stimulus such as the aggregation of IgE antibody bound to high-affinity IgE receptors by specific antigen. This process is therefore referred to as regulated exocytosis. A characteristic of mast cell exocytosis is that it does not involve release of a few individual granules, but rather, a large fraction of the granular content is released due to compound exocytosis, implicating the occurrence of granule-to-granule and granule-to-plasma membrane fusion. This unit describes assays that measure the release of granular content from mast cells. They include in vitro colorimetric-, radiolabel-, or antibody detection-based assays for substances stored in the granules. Given that animal models for basophil and mast cell activation are being used with increasing frequency, the unit also includes protocols to measure exocytosis of mast cell granule content in vivo.

Mesh:

Substances:

Year:  2006        PMID: 18228478     DOI: 10.1002/0471143030.cb1511s32

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  13 in total

1.  Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells.

Authors:  Ryo Suzuki; Xibao Liu; Ana Olivera; Lizath Aguiniga; Yumi Yamashita; Ulrich Blank; Indu Ambudkar; Juan Rivera
Journal:  J Leukoc Biol       Date:  2010-06-22       Impact factor: 4.962

2.  Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen.

Authors:  Peter E Deak; Baksun Kim; Amina Abdul Qayum; Jaeho Shin; Girish Vitalpur; Kirsten M Kloepfer; Matthew J Turner; Neal Smith; Wayne G Shreffler; Tanyel Kiziltepe; Mark H Kaplan; Basar Bilgicer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

3.  Ikaros limits basophil development by suppressing C/EBP-α expression.

Authors:  Kavitha N Rao; Craig Smuda; Gregory D Gregory; Booki Min; Melissa A Brown
Journal:  Blood       Date:  2013-08-29       Impact factor: 22.113

4.  Update on Eosinophil Interaction with Mast Cells: The Allergic Effector Unit.

Authors:  Roopesh Singh Gangwar; Hadas Pahima; Pier Giorgio Puzzovio; Francesca Levi-Schaffer
Journal:  Methods Mol Biol       Date:  2021

5.  Measuring mast cell mediator release.

Authors:  Hye Sun Kuehn; Madeleine Radinger; Alasdair M Gilfillan
Journal:  Curr Protoc Immunol       Date:  2010-11

6.  Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation.

Authors:  Michael W Handlogten; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

7.  PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.

Authors:  Yasuko Furumoto; Nicolas Charles; Ana Olivera; Wai Hang Leung; Sandra Dillahunt; Jennifer L Sargent; Kevin Tinsley; Sandra Odom; Eric Scott; Todd M Wilson; Kamran Ghoreschi; Manfred Kneilling; Mei Chen; David M Lee; Silvia Bolland; Juan Rivera
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

8.  Synthetic allergen design reveals the significance of moderate affinity epitopes in mast cell degranulation.

Authors:  Michael W Handlogten; Tanyel Kiziltepe; Nathan J Alves; Basar Bilgicer
Journal:  ACS Chem Biol       Date:  2012-08-21       Impact factor: 5.100

9.  A heterobivalent ligand inhibits mast cell degranulation via selective inhibition of allergen-IgE interactions in vivo.

Authors:  Michael W Handlogten; Ana P Serezani; Anthony L Sinn; Karen E Pollok; Mark H Kaplan; Basar Bilgicer
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

10.  Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis.

Authors:  Melanie C Dispenza; Rebecca A Krier-Burris; Krishan D Chhiba; Bradley J Undem; Piper A Robida; Bruce S Bochner
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.